2021
DOI: 10.1080/00015458.2021.1922829
|View full text |Cite
|
Sign up to set email alerts
|

Oncological safety of therapeutic ‘nipple-sparing mastectomy’ followed by reconstruction: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
2
0
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 37 publications
1
2
0
1
Order By: Relevance
“…5 A recent systematic review found locoregional recurrence rates for nipple-sparing mastectomy at median 5-year follow up to be 0 to 7.4 percent. 19 With 7-year median follow-up, Wu and colleagues report a locoregional recurrence rate of 3.5 percent, comparable to the rate described in our cohort. 20 Li and associates examined 763 patients from the Surveillance, Epidemiology, and End Results database with a mean 5.7-year follow-up.…”
Section: Discussionsupporting
confidence: 86%
“…5 A recent systematic review found locoregional recurrence rates for nipple-sparing mastectomy at median 5-year follow up to be 0 to 7.4 percent. 19 With 7-year median follow-up, Wu and colleagues report a locoregional recurrence rate of 3.5 percent, comparable to the rate described in our cohort. 20 Li and associates examined 763 patients from the Surveillance, Epidemiology, and End Results database with a mean 5.7-year follow-up.…”
Section: Discussionsupporting
confidence: 86%
“…In a recent systematic review, locoregional recurrence was found to be 0%-7.4% after a median 5-year follow-up and no increased risk of recurrence with reconstructive method[ 45 ]. In a 7-year median follow-up study, locoregional recurrence in patients with immediate breast reconstruction was found to be 3.5% and independent from the reconstructive method[ 46 ].…”
Section: Implant-based Reconstructionmentioning
confidence: 99%
“…Several studies with long follow up have demonstrated the oncological safety of SSM [ 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. As surgical innovation has progressed, preservation of the nipple as part of the native skin of the breast, known as nipple-sparing mastectomy (NSM), has become acceptable from an oncologic perspective [ 14 , 15 , 16 ]. Galimberti et al [ 17 ] reviewed 1989 patients who had undergone NSM as a therapeutic procedure.…”
Section: Introductionmentioning
confidence: 99%